Apeloa Pharmaceutical Co Ltd Class A 000739
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- CNY 15.79
- Day Range
- CNY 15.70–16.15
- 52-Week Range
- CNY 10.66–19.99
- Bid/Ask
- CNY 15.83 / CNY 15.84
- Market Cap
- CNY 18.66 Bil
- Volume/Avg
- 16.2 Mil / 17.7 Mil
Key Statistics
- Price/Earnings (Normalized)
- 17.86
- Price/Sales
- 1.59
- Dividend Yield (Trailing)
- 1.88%
- Dividend Yield (Forward)
- 1.88%
- Total Yield
- 1.88%
Company Profile
Apeloa Pharmaceutical Co Ltd is a pharmaceutical company. It is engaged in research and development, manufacturing and marketing of APIs formulations and veterinary drugs. It offers products including Ofloxacin, Levofloxacin Hydrochloride, Marbofloxacin, and others.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Mid Core
- Total Number of Employees
- 7,208
- Website
- http://www.apeloa.com
Comparables
Valuation
|
Metric
|
000739
|
600216
|
600521
|
|---|---|---|---|
Price/Earnings (Normalized) | 17.86 | 51.39 | 24.41 |
Price/Book Value | 2.88 | 1.06 | 3.10 |
Price/Sales | 1.59 | 1.29 | 2.89 |
Price/Cash Flow | 16.96 | 16.24 | 9.37 |
Price/Earnings
000739
600216
600521
Financial Strength
|
Metric
|
000739
|
600216
|
600521
|
|---|---|---|---|
Quick Ratio | — | 1.54 | 0.81 |
Current Ratio | — | 2.38 | 1.33 |
Interest Coverage | — | 13.45 | 6.22 |
Quick Ratio
000739
600216
600521
Profitability
|
Metric
|
000739
|
600216
|
600521
|
|---|---|---|---|
Return on Assets (Normalized) | 8.04% | 1.27% | 5.62% |
Return on Equity (Normalized) | 17.08% | 1.68% | 13.24% |
Return on Invested Capital (Normalized) | 13.90% | 1.59% | 7.70% |
Return on Assets
000739
600216
600521
Drug Manufacturers - Specialty & Generic Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ZTS
| Zoetis Inc Class A | Rsdskkybvx | Sdl | $79.1 Bil | |
MKKGY
| Merck KGaA ADR | Psfrltddc | Tvzcqt | $74.3 Bil | |
HLN
| Haleon PLC ADR | Rgflnzxg | Wqjh | $38.1 Bil | |
TEVA
| Teva Pharmaceutical Industries Ltd ADR | Wgjpcgk | Gyy | $19.1 Bil | |
VTRS
| Viatris Inc | Wbwpdmtg | Zxgxs | $13.2 Bil | |
RDY
| Dr Reddy's Laboratories Ltd ADR | Qycxvlvjn | Lzyj | $11.7 Bil | |
CTLT
| Catalent Inc | Nqxjqtdvw | Vcxtryh | $10.0 Bil | |
CURLF
| Curaleaf Holdings Inc | Nfcqsrg | Zfzt | $4.2 Bil | |
PRGO
| Perrigo Co PLC | Wqmfrdpj | Xpjp | $4.1 Bil | |
PBH
| Prestige Consumer Healthcare Inc | Dycxrlj | Cgsqtz | $3.3 Bil |